Chengdu Kanghua Biological Products Co., Ltd. (SHE:300841)
China · Delayed Price · Currency is CNY 56.03
+1.57 (2.88%)
Sep 23, 2026, 3:04 PM CST
SHE:300841 Market Cap
SHE:300841 has a market cap or net worth of 7.28 billion as of September 23, 2026. Its market cap has decreased by -25.74% in one year.
Market Cap
7.28B
Enterprise Value
6.25B
Revenue
1.22B
Ranking
n/a
PE Ratio
29.53
Stock Price
56.03
ChartMarket Cap Chart
Since June 16, 2020, SHE:300841's market cap has increased from 6.08B to 7.28B, an increase of 19.76%. That is a compound annual growth rate of 2.92%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 23, 2026 | 7.28B | -22.46% |
| Dec 31, 2025 | 9.39B | 34.30% |
| Dec 31, 2024 | 6.99B | -32.58% |
| Dec 29, 2023 | 10.37B | -8.37% |
| Dec 30, 2022 | 11.32B | -40.88% |
| Dec 31, 2021 | 19.14B | -31.86% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jun 16, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Bio-Thera Solutions | 8.02B |
| Daan Gene | 7.89B |
| Innovita Biological Technology | 7.65B |
| China Resources Boya Bio-pharmaceutical Group Co.,Ltd | 7.47B |
| Novogene | 7.36B |
| Star Lake Bioscience Co., Inc.Zhaoqing Guangdong | 7.03B |
| Jiangsu Aidea Pharmaceutical Group | 6.98B |
| PharmaResources (Shanghai) | 6.96B |